Frequency and E-field Enhancement of ITBS for Depression (FREED)
NCT06003309 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2026-02-13
Summary
The investigators propose a randomized 3-arm double-blinded parallel experimental trial (20 sessions over 4 weeks) in 75 patients with TRD. The three arms include (1) the combination of a fully Individualized form of intermittent Theta Burst Stimulation (iTBS) (using BOTH the frequency and electric field (E-field) targeting approaches) (Ind-iTBS)), (2) iTBS individualized using E-field targeting only (targeted-iTBS) and (3) Standard iTBS treatment (i.e., typical iTBS localized to the dorsolateral prefrontal cortex (DLPFC) using the Beam F3 method). Electroencephalography (EEG) data will be collected at rest and during a working memory task, at baseline, and at the end of treatment along with clinical assessments of depression severity. The target engagement dependent variable of interest in these three arms will be fronto-parietal theta connectivity measured through resting-state EEG. The investigators hypothesize that stimulation with Ind-iTBS will lead to greater changes in fronto-parietal theta connectivity than that produced with targeted-TBS and standard iTBS. Aim: To evaluate the effects of two individualized forms of iTBS (i.e., using BOTH the frequency and E-field individualization; Ind-iTBS) compared to iTBS individualized for E-field targeting only (targeted-iTBS) and standard iTBS on fronto-parietal theta connectivity. Hypotheses: (1) Ind-iTBS will lead to greater changes in fronto-parietal theta connectivity compared to both targeted-iTBS and standard iTBS. (2) Ind-iTBS will also lead to a greater reduction in depressive symptoms (as defined by the mean reduction in Montgomery Åsberg Depression Rating Scale Scores (MADRS)) compared to both targeted-iTBS and standard iTBS.
Conditions
Interventions
- DEVICE
-
Transcranial Magnetic Stimulation (TMS) - Fully Individualized iTBS
Repetitive transcranial magnetic stimulation (rTMS) is a safe and effective treatment for TRD that is increasingly being used in clinical practice across the world. It's mechanism of action is based on Farady Law of electromagnetic induction where the magnetic field produced by TMS coil induces electric field in the neurons. In the Ind-iTBS, the coil placement and current amplitude will be provided using individualized E-field modelling and coordinate-based cortical targeting. The stimulation frequency will also be individualized according to EEG-derived TGC.
- DEVICE
-
Transcranial Magnetic Stimulation (TMS) - targeted-iTBS
Repetitive transcranial magnetic stimulation (rTMS) is a safe and effective treatment for TRD that is increasingly being used in clinical practice across the world. It's mechanism of action is based on Farady Law of electromagnetic induction where the magnetic field produced by TMS coil induces electric field in the neurons. In the targeted-iTBS, the coil placement and current amplitude will be provided using individualized E-field modelling and coordinate-based cortical targeting.
- DEVICE
-
Transcranial Magnetic Stimulation (TMS) - Standard-iTBS
Repetitive transcranial magnetic stimulation (rTMS) is a safe and effective treatment for TRD that is increasingly being used in clinical practice across the world. It's mechanism of action is based on Farady Law of electromagnetic induction where the magnetic field produced by TMS coil induces electric field in the neurons. The standard iTBS will be delivered with the typical 5Hz/50Hz patterned frequencies used in the FDA approved treatment protocol and stimulation will be delivered according to the Beam F3 targeting.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
University of California, San Diego
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-31
- Primary Completion
- 2025-12-30
- Completion
- 2025-12-30
- FDA Device
- Yes
Countries
- United States
- Australia
Study Locations
More Related Trials
-
Right-sided 1-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) Versus Left-sided Intermittent Theta Burst Stimulation (iTBS) in Patients With Depression
NCT07026461 ·Status: RECRUITING ·Phase: PHASE4
-
Transcranial Magnetic Stimulation vs Theta Burst Stimulation in Major Depressive Disorder
NCT04497350 ·Status: UNKNOWN ·Phase: NA
-
Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation
NCT04243798 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Biomarkers of Response of TBS in Treatment Resistant Depression
NCT04998773 ·Status: RECRUITING ·Phase: NA
-
The Antidepressant Effect of Intermittent Theta Burst Stimulation (iTBS)
NCT05516095 ·Status: COMPLETED ·Phase: NA
-
Neuromodulation and Attention Deficits in MDD
NCT07111169 ·Status: RECRUITING ·Phase: NA
-
Theta Burst Stimulation in Pharmacologically Untreated Patients as Sole Antidepressant Treatment
NCT05732298 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study
NCT03680781 ·Status: COMPLETED ·Phase: NA
-
Olfactory and Brain Stimulations in Treatment-resistant Depression
NCT05661383 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Theta-burst Stimulation (TBS) in Patients With Major Depression
NCT01240083 ·Status: COMPLETED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation in Pharmaco-naïve Patients With Major Depression
NCT04000022 ·Status: UNKNOWN
-
Pilot Study Comparing 10hz vs Theta Burst Stimulation
NCT02800226 ·Status: COMPLETED ·Phase: PHASE3
-
Theta Burst Stimulation With an 8-Coil Versus H1-Coil for Resistant Depression
NCT06813313 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Rapid Acting Transcranial Magnetic Stimulation
NCT04739969 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment for Major Depressive Disorder With Intermittent Theta-burst Stimulation
NCT05390593 ·Status: UNKNOWN ·Phase: NA
-
Effect of Intermittent ThetaBurst Stimulation in Treatment-resistant Bipolar Depression
NCT02740244 ·Status: TERMINATED ·Phase: NA
-
Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression
NCT05422417 ·Status: RECRUITING ·Phase: NA
-
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder
NCT05849402 ·Status: RECRUITING ·Phase: NA
-
Neural Mechanisms of Intermittent Theta Burst Stimulation in the Core Depression Network
NCT05224206 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Psilocybin rTMS for Treatment Resistant Depression
NCT06132178 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment, Emotion, and Neuromodulation of Depression (TREND) Study
NCT05436379 ·Status: COMPLETED ·Phase: NA
-
Resting-state Functional Connectivity Throughout a Course of iTBS in Major Depression
NCT03944213 ·Status: UNKNOWN
-
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
NCT04392947 ·Status: COMPLETED ·Phase: NA
-
Intermittent Theta-burst Stimulation for Major Depression: an Intensity-response Study
NCT06392867 ·Status: RECRUITING ·Phase: NA
-
Theta-Burst Stimulation in Major Depressive Episodes With Mixed Characteristics.
NCT04123301 ·Status: UNKNOWN ·Phase: NA